Published in Behring Inst Mitt on May 01, 1984
Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Br J Cancer (1996) 1.84
Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy. Eur J Cancer (1979) 1.49
Immunohistochemical detection of the multi-drug-resistance marker P-glycoprotein in uterine cervical carcinomas and normal cervical tissue. Am J Obstet Gynecol (1992) 1.43
P-glycoprotein expression in treated and untreated human breast cancer. Br J Cancer (1989) 1.39
Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy. J Clin Oncol (2001) 1.18
Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis. Int J Cancer (1998) 1.18
Clinical relevance of predictive tests for cancer chemotherapy. Cancer Treat Rev (1982) 1.16
Prognostic relevance of ploidy, proliferation, and resistance-predictive tests in ovarian carcinoma. Cancer Res (1985) 1.15
Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance. Int J Cancer (1999) 1.10
Depressive action of serum of partially hepatectomized rats on tumour cells in vitro. Eur J Cancer (1967) 1.08
Tumour induction in the rodent Mastomys natalensis by activation of endogenous papilloma virus genomes. Nature (1984) 1.05
DNA distribution in non-small-cell lung carcinomas and its relationship to clinical behavior. Cytometry (1985) 1.04
Glucose-related protein (GRP78) and its relationship to the drug-resistance proteins P170, GST-pi, LRP56 and angiogenesis in non-small cell lung carcinomas. Anticancer Res (2000) 1.02
Prognostic significance of DNA patterns and resistance-predictive tests in non-small cell lung carcinoma. Cancer (1985) 1.00
Reciprocal correlation between expression of P-glycoprotein and accumulation of rhodamine 123 in human tumors. Anticancer Res (1990) 0.98
[Selective tumour chemotherapy using oncobiograms (author's transl)]. Dtsch Med Wochenschr (1974) 0.97
Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density. Anticancer Res (1997) 0.95
Growth of human bronchial carcinomas in nude mice. Br J Cancer (1985) 0.93
Human tumor xenografts as model for drug testing. Cancer Metastasis Rev (1988) 0.93
[Possibilities and limits of pre-therapeutic neoplasm sensitivity cytostatics tests under short-term conditions]. Schweiz Med Wochenschr (1975) 0.93
Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real-time quantitative polymerase chain reaction. Clin Cancer Res (2001) 0.92
[Quick method for sensitivity tests of malignant tumors against antineoplastic agents]. Klin Wochenschr (1970) 0.90
Detection of drug resistance and P-glycoprotein in human renal cell carcinomas. Eur Urol (1990) 0.90
Overexpression of oncoproteins in non-small cell lung carcinomas of smokers. Carcinogenesis (1993) 0.90
Incorporation of 131 iododeoxyuridine into the DNA of tumour-bearing rats after partial synchronization as a tool in scintigraphic tumour localization. Nucl Med (Stuttg) (1974) 0.89
Vascular endothelial growth-factor expression and angiogenesis in nonsmall cell lung carcinomas. Int J Oncol (1995) 0.89
Clinical correlates of in vitro effect of adriamycin on advanced lung carcinoma. Klin Wochenschr (1976) 0.88
Smoking-related increase of O6-methylguanine-DNA methyltransferase expression in human lung carcinomas. Carcinogenesis (1998) 0.87
Relationship between the expression of caspase-3 and the clinical outcome of patients with non-small cell lung cancer. Anticancer Res (2000) 0.87
Messenger RNA expression of resistance proteins and related factors in human ovarian carcinoma cell lines resistant to doxorubicin, taxol and cisplatin. Anticancer Drugs (1997) 0.85
Association of vascular endothelial growth factor expression with tumor cell proliferation in ovarian carcinoma. Anticancer Res (1997) 0.85
Concurrent paclitaxel and radiation therapy for breast cancer. Semin Radiat Oncol (1999) 0.85
Association of resistance-related protein expression with poor vascularization and low levels of oxygen in human rectal cancer. Int J Cancer (1996) 0.84
Isopycnic density-gradient centrifugation: a separation parameter which improves flow cytometric measurements on heterogeneous tumors. Cytometry (1983) 0.84
[Incorporation of a 131-iodine-deoxycytidine monophosphate protamine complex into the DNA of tumor-bearing rats following partial synchronization with hydroxyurea]. Nucl Med (Stuttg) (1975) 0.84
Sensitivity tests of tumors to cytostatic agents. I. Comparative investigations on transplanted tumors in vivo and in vitro. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1975) 0.84
Kinetic complexity of nuclear poly(A)-containing RNA in normal and regenerating rat liver. Eur J Biochem (1979) 0.84
O6-methylguanine-DNA methyltransferase activity and sensitivity to cyclophosphamide and cisplatin in human lung tumor xenografts. Int J Cancer (1998) 0.84
Occurrence of a multidrug-resistant phenotype in human lung xenografts. Br J Cancer (1987) 0.83
Reversal of doxorubicin-resistance in sarcoma 180 tumor cells by inhibition of different resistance mechanisms. Cancer Lett (1993) 0.82
Analysis of cyclin D1 in de novo and relapsed childhood acute lymphoblastic leukemia. Anticancer Res (1999) 0.82
Sensitivity tests of tumors to cytostatic agents. II. Investigation on human tumors. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1975) 0.82
[Individual chemotherapy of solid tumors]. Med Welt (1976) 0.82
Resistance to doxorubicin in tumor cells in vitro and in vivo after pretreatment with verapamil. Chemotherapy (1991) 0.82
Up-regulation of resistance-related proteins in human lung tumors with poor vascularization. Carcinogenesis (1995) 0.81
Overexpression of P-glycoprotein in human lung carcinoma xenografts after fractionated irradiation in vivo. Radiat Res (1991) 0.80
P-glycoprotein and glutathione S-transferase pi in childhood acute lymphoblastic leukaemia. Br J Cancer (1994) 0.80
Deoxycytidine kinase mRNA expression in childhood acute lymphoblastic leukemia. Anticancer Drugs (1997) 0.80
Different growth rates of lung tumours in man and their xenografts in nude mice. Eur J Cancer (1980) 0.80
Reversal of doxorubicin-resistance in solid tumors by clomipramine. In Vivo (1995) 0.80
[Effect of carcinogenic nitrosamines and nitrosamides on the incroporation of 3H-thymidine, 3H-uridine and 3H-leucine into Tetrahymena, L-cells and liver explants]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 0.80
Biological characterization of subgroups of squamous cell lung carcinomas. Clin Cancer Res (1999) 0.80
Rapid screening of macromolecular synthesis in single cell cultures. Naturwissenschaften (1968) 0.79
[Sensitivity tests of human malignant tumors to cytostatic drugs]. Klin Wochenschr (1971) 0.79
Expression of heat shock proteins, glutathione peroxidase and catalase in childhood acute lymphoblastic leukemia and nephroblastoma. Cancer Lett (1996) 0.79
Expression of metallothionein in initial and relapsed childhood acute lymphoblastic leukemia. Ann Hematol (1994) 0.79
nm23-H1 protein expression in newly diagnosed and relapsed childhood acute lymphoblastic leukemia. Anticancer Res (1999) 0.79
The effects of cytostatic drugs on transplanted tumours. An investigation of the correlation between in vivo and in vitro results. Arch Geschwulstforsch (1974) 0.79
Maintenance of morphology and tumour marker production in human epidermoid lung carcinoma xenografts. In Vivo (1992) 0.79
Microvessel density and vascular endothelial growth factor expression in human tumors of different localization. Oncol Rep (1996) 0.79
In-vitro testing of cyclophosphamide on tumors. Naturwissenschaften (1975) 0.79
Growth kinetics of human lung tumours in nude mice. Exp Cell Biol (1981) 0.79
Messenger RNA expression of resistance factors and their correlation to the proliferative activity in childhood acute lymphoblastic leukemia. Cancer Lett (1995) 0.78
Taxanes in adjuvant and neoadjuvant therapies for breast cancer. Oncology (Williston Park) (1998) 0.78
Vascular liver tumors induced in Mastomys (Praomys) natalensis by single or twofold administration of dimethylnitrosamine. J Natl Cancer Inst (1979) 0.78
Influence of hormone therapy on human lung tumors transplanted into nude mice. Oncology (1985) 0.78
Predicting chemosensitivity of tumors. Breast Cancer Res Treat (1986) 0.78
Changes in the concentrations of elements in liver after partial hepatectomy. Experientia (1974) 0.78
Albumin messenger RNA after partial hepatectomy and sham operation. Biochim Biophys Acta (1980) 0.78
[Prognostic significance of flow cytophotometric studies in ovarian cancer]. Geburtshilfe Frauenheilkd (1987) 0.78
Differential expression of intermediate-filament proteins in murine sarcoma 180 ascites or solid tumor. Cancer Res (1984) 0.78
[Sensitivity testing of malignant human tumors against cytostatic agents. II]. Klin Wochenschr (1972) 0.78
Expression of resistance-related proteins in tumoral and peritumoral tissues of patients with lung cancer. Cancer Lett (1996) 0.78
Apoptotic index, Fas and bcl-2 in initial and relapsed childhood acute lymphoblastic leukaemia. Apoptosis (1997) 0.78
Flow cytometric analysis of primary lung carcinomas and their lymph node metastases. Anticancer Res (1987) 0.78
Multiple resistance mechanisms in acute nonlymphoblastic leukemia (ANLL). Anticancer Res (1998) 0.78
Green tea catechins (EGCG and EGC) have modulating effects on the activity of doxorubicin in drug-resistant cell lines. Anticancer Drugs (1997) 0.78
Immunohistochemical detection of P glycoprotein, glutathione S transferase and DNA topoisomerase II in human tumors. Oncology (1992) 0.77
[Rapid determination of DNA synthesis with 3H-thymidne]. Naturwissenschaften (1968) 0.77
Detection of P-glycoprotein in human leukemias using monoclonal antibodies. Blut (1989) 0.77
Modulation of doxorubicin-toxicity by tamoxifen in multidrug-resistant tumor cells in vitro and in vivo. J Cancer Res Clin Oncol (1994) 0.77
Modulation of P-glycoprotein-mediated multidrug resistance by monoclonal antibodies, immunotoxins or antisense oligodeoxynucleotides in kidney carcinoma and normal kidney cells. Oncology (1993) 0.77
nm23-H1 expression defines a high-risk subpopulation of patients with early-stage epithelial ovarian carcinoma. Br J Cancer (2000) 0.77
High rate of expression of multidrug resistance-associated P-glycoprotein in human endometrial carcinoma and normal endometrial tissue. Eur J Cancer (1993) 0.77
[Testing of the resistance of human tumours in the short-term test (author's transl)]. Klin Wochenschr (1975) 0.77
Effect of five antineoplastic agents on tumor xenografts with different growth rates. J Natl Cancer Inst (1984) 0.77
[The effects of cytostatic agents on short-term cultures (3H-uridine incorporation) and tissue cultures (cell counts) from human tumors (author's transl)]. Arch Gynakol (1974) 0.77
Development of drug resistance in a human epidermoid lung carcinoma xenograft line. Br J Cancer (1988) 0.77
Correlations between natural resistance to doxorubicin, proliferative activity, and expression of P-glycoprotein 170 in human kidney tumor cell lines. Urol Res (1990) 0.77
Reversal of inherent multidrug-resistance in primary human renal cell carcinoma cell cultures by S 9788. Anticancer Res (1993) 0.77
[Resistance testing of malignant tumors]. MMW Munch Med Wochenschr (1977) 0.77
[The effect of cyclophosphamide on tumors in the sensitivity-test (author's transl)]. Arch Gynakol (1975) 0.77
Detection of induced resistance in short-term-tests. Adriamycin-resistant sarcoma 180. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1978) 0.77
Detection of induced resistance to cytosine-arabinoside with a short-term test. Eur J Cancer (1980) 0.76
[Oncobiograms and cancer chemotherapy: Hope or reality? (author's transl)]. Langenbecks Arch Chir (1975) 0.76
In vivo and in vitro detection of induced resistance to daunorubicin in murine leukemia L 1210. Arzneimittelforschung (1981) 0.76
Nonsteroidal and steroidal aromatase inhibitors in breast cancer. Oncology (Williston Park) (2001) 0.76
Resistance mechanisms in human lung cancer. Invasion Metastasis (1995) 0.76
Messenger RNA expression of resistance factors in human tumor cell lines after single exposure to radiation. J Exp Ther Oncol (1996) 0.76
Expression of the retinoblastoma tumor suppressor gene (RB-1) in acute leukemia. Leuk Lymphoma (1998) 0.76